From research to innovation
He was PI of several investigator-driven multicenter randomized clinical trials including the game-changing MR CLEAN (Multicenter Randomized Clinical trial of Endovascular treatment for acute ischemic stroke in the Netherlands).
He is now Research Leader of CONTRAST, the Collaboration for New Treatments for Acute Stroke, a large private-public funded body uniting clinical and experimental academic researchers in the Netherlands.
A new, effective treatment for stroke: the impact and spin-off of endovascular thrombectomy
Every 15 minutes, someone in the Netherlands is struck by stroke, which is caused by an occluded blood vessel in the brain. This means severe handicap for every second person and death for every tenth. The MR CLEAN trial was the first study worldwide to prove that endovascular thrombectomy not only reopens the blood vessel, but also improves recovery, The investigators have now set up the large, charity- and industry-supported CONTRAST consortium to further improve treatment of acute stroke.